Notably, the elevated level of CD19+ B cells and immunoglobulins among our patients with cutaneous involvements could result from the contribution of these immune mediators in developing eczema/dermatitis and autoimmune cutaneous manifestations in the patients [22,23]. Here, CD19 is linked to Eczematoid dermatitis.